Trading leveraged product involves significant risk of loss. 24.46% of retail investor accounts generate profits when trading leveraged products with this provider

RESMED Stock (RMD.re) Price Chart, Analysis, and Forecast

View the real-time RESMED (RMD.re) stock quote and decide if you want to buy and when to sell. Find predictions, financials, the latest news and other information to help you with your stock investing.

Buy
Sell
Daily price range:
Trade [object Object]

All investing involves risk

live price

Live Chart

Past performance is not a reliable indicator of future results.

Is RESMED a good stock to buy?

The quantitative stock rating system created by TipRanks shows that RESMED price is neutral. Its Smart Score¹ of 5 indicates RESMED is a top stock to add to your watchlist.

5

Smart Score

Why is RESMED stock price going up?

RESMED

Bulls say

  • Capital allocation

    Sale of MatrixCare provides cash earmarked for accelerated share repurchases, which could support per‑share returns and bolster shareholder value.

  • Portfolio optimization

    Divesting the underperforming residential care software business narrows focus on core sleep apnea solutions, improving portfolio quality and supporting a return to stronger SaaS revenue growth.

  • Strategic acquisition

    Acquisition of a restless leg syndrome specialist broadens clinical offerings and creates cross‑selling opportunities with obstructive sleep apnea treatments, supporting revenue expansion.

  • Product safety and supply

    Field safety notice for certain ventilators and severely limited availability of replacement circuit boards risk therapy interruptions and constrain repair capacity and device supply.

  • Earnings dilution and accounting loss

    Sale of the software business at a price below its original purchase may create a non‑cash accounting loss and, combined with the Noctrix deal, is expected to reduce adjusted earnings per share.

  • Margin pressure

    Rising component costs for printed circuit boards and adverse currency movements are prompting more conservative gross margin assumptions and could squeeze profitability.

Why is RESMED stock price going down?

RESMED

Bears say

    No bearish insights available yet.

What is happening with
RESMED stock price today?

  • The price of RESMED today, as of , was $. That's down % from the previous session's RESMED closing price.

  • The RESMED price is declining this week. Compared to last week, the rate of RESMED is down --, and it's down -- from one month ago.

  • The 52-week RESMED price high is $, while the 52-week RESMED price low is $.

  • Year to date, RESMED price is down -- from the beginning of the year and has had a return of -- in the last 12 months.

What is the sentiment of RESMED stock in July 2026?

The sentiment score², indicating how the crowd feels about RESMED stock is NEUTRAL. The sentiment signal³ observed at the start of the market session, offering insights into whether RESMED stock price today is likely to increase, decrease, or remain steady, is NEUTRAL.

News Sentiment
Very Bearish
Very Bearish
Bullish: 0%Bearish: 100%
Blogger Opinion
Bullish
Bullish
Bullish: 85%Bearish: 15%
Investors Sentiment
Very Negative
Very Negative
Past 7d: 1%Past 30d: -15%

Table with the sentiment of RESMED stock in July 2026

RESMED stock analysis

Based on analysts giving ratings to RESMED stock, the consensus⁴ is BUY. Hedge funds activity⁵ decreased in the last quarter, while Insider activity⁶ trend is N/A (N/A RESMED shares)

RESMED Technical Analysis

Trending downNegative
SMA
Trending down-0.19
Momentum

Simple moving average: 20/200 days

Momentum: 12 month change

RESMED Insider Activity

No data available

RESMED Fundamentals

Trending up+24.0%
Return on equity
Trending up+16.0%
Asset Growth

Return on equity: last 12 months

Asset growth: 12 month change

Discover key RESMED stock trends with NAGA Insights

What am I Missing?

  • Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.

  • Access advanced RESMED charting, technical analysis, and live market data from TradingView.

  • Get AI-powered RESMED trade signals, in-depth market analysis, and technical strategy insights from Trading Central.

Sign up

All investing involves risk

Best Stocks Discover

RESMED stock outlook 2026

Analysts forecast RESMED stock price will rise/fall in the next 12 months. Based on 13 Wall Street analysts offering RESMED price predictions in the last 3 months, the average price target is $240.73.

The highest RESMED stock forecast is $320.00, while the lowest is $220.00. The average RESMED price target represents a 20.98% change from the actual price of $.

RESMED stock price prediction⁷

  • Highest price target$320.00
  • Average price target$240.73
  • Lowest price target$220.00

RESMED stock forecast⁸

  • Buy30.77%
  • Hold69.23%
  • Sell0.00%

Overview of stock forecast and price predictions 2026. Analyst price targets and consensus are estimates only and do not constitute guarantees of future outcomes.

Investing in RESMED stock

There are two ways to invest in RESMED stock: trading RESMED stock through derivatives like CFDs or buying shares of RESMED stock outright. With NAGA.com, you can do both and more.


Buy RESMED shares of stock if you want to hold them for a long time. You commit the full value of the RESMED shares outright and profit only if they increase in price.


Trade RESMED if you want more flexibility — say you want to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think RESMED stock’s price will rise, or you can open a sell position (go short) if you believe the RESMED stock’s price will fall.


You won’t need to commit to the full value of the position. But bear in mind that leverage can increase both your profits and losses.

How to invest

How to trade RESMED with CFDs?

  • If you want to speculate on RESMED price, search for RESMED CFD. Then click on the "RESMED" symbol to view the chart and other insights before placing your trade. Also, review "RESMED" contract specification to be aware of all the RESMED CFD trading conditions.

How to buy RESMED stock?

  • If you want to buy RESMED shares outright to hold them for a long time, search for RESMED stock with ownership (Real Stocks). Then click on the "RESMED" symbol to view the chart and other insights before placing your trade. Also, review "RESMED" contract specification to be aware of all the RESMED stock buying conditions.

trading conditions:

Platform
MT5
Ticker
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission
Monthly price change (%)0.00%
Annual price change (%)0.00%
Digits
Tick value
Trading Hours & Fees
Get Started

All investing involves risk

RESMED company presentation

RMD

ResMed

Real Stocks

--
--

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Latest RESMED stock news

Discover the latest news that can influence RESMED’s earnings sentiment and RESMED forecast and price predictions.

Neutral
SpaceX initiated, Lululemon downgraded: Wall Street’s top analyst calls
16/07/2026/09:35
Read more
Negative
ResMed downgraded to Sector Perform from Outperform at RBC Capital
16/07/2026/06:30
Read more
Neutral
ResMed price target lowered to $220 from $235 at Mizuho
15/07/2026/07:32
Read more

FAQs about RESMED trading

The price of RESMED stock today, as of , was . That's down % from the previous session's RESMED closing price.

IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ ⁵ ⁶ The Smart Score is a proprietary quantitative stock scoring system created by TipRanks. It assigns stocks a score from one to ten, based on 8 market key factors. The lowest score is 1, and the highest is 10. Stocks with a score of 8, 9, or 10 are considered Outperform, and with a score of 1, 2, or 3 are considered Underperform. The score is data-driven and does not involve any human intervention. The contributing market factors are Wall Street analyst ratings, Corporate insider transactions, Financial blogger opinions, Individual investor sentiment, Hedge fund manager activity, News sentiment, Technicals and Fundamentals. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ⁴ ⁷ ⁸ TipRanks’ consensus ratings provide an aggregated view of expectations and consensus on a particular stock from a wide range of global analyst opinions. They’re then condensed into a single indicator, which can help you make investment decisions based on expert analysis. TipRanks’ 12-month forecast is a consensus price target derived from Wall Street analysts’ projections made over the past three months. It forecasts the potential high, low, and average share price for a stock one year from now, along with the average expected upside or downside percentage. ² ³ The sentiment signal and sentiment score are provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.

Need Help? Visit our Help Section
Download NAGA Trader

Copyright © 2026 – All rights reserved.

NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.

The website is operated by KEY WAY MARKETS LTD a Company limited by shares that is formed and registered under the Laws of the Abu Dhabi Global Market (“ADGM”) under license number 000003041, authorized and regulated by the Financial Services Regulatory Authority (“FSRA”) with Financial Services Permission Number 190005, having its registered offices at Office 2, 21st Floor, Al Sila Tower, ADGM Square, Al Maryah Island, Abu Dhabi, United Arab Emirates (“the Company”).

The Company is authorized to provide financial products and services to Retail Clients and to persons who meet the qualifying criteria of a Professional Client as defined in the ADGM Conduct of Business Module. Other group entities: NAGA Markets Europe Ltd, authorized and regulated by the Cyprus Securities and Exchange Commission ("CySEC") under license No. 204/13 with registered address at Agias Zonis 11, Limassol, 3027, Cyprus.

RISK WARNING: Trading leveraged products (CFDs) and real shares involves significant risk, including the potential loss of your initial investment, and may not be suitable for all investors. Before trading or investing, you are strongly advised to read and ensure you understand the relevant Risk Disclosure and warnings included in the Company's legal documents section. There is a substantial risk that you may lose all of your initial investment when trading or investing. We recommend that you carefully consider whether trading leveraged products or investing in shares is appropriate for you in light of your personal circumstances, and ensure you fully understand all associated risks before proceeding. 24.46% of retail investor accounts generate profits when trading leveraged products with this provider. Trading with NAGA Trader by following and/or copying or replicating the trades of other traders involves high levels of risks, even when following and/or copying or replicating the top-performing traders. Such risks include the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders, or traders whose ultimate purpose or intention, or financial status may differ from yours. Before making an investment decision, you should rely on your own assessment of the person making the trading decisions and the terms of all the legal documentation.

Disclaimer: The content on this page is for informational purposes only and is not intended as a recommendation or advice. Any references to past performance, emulated performance, or forecasts in the Company’s advertisements are not reliable indicators of future results. Customers are solely responsible for their own business decisions or investments.